The test proves that the specific markers can be very effectively used for distinguishing the cancer tissue and para-carcinoma tissue of the patient suffering from the primary liver cancer.何祥火魏霖梁琳慧顾健人
Discovery of New Markers of Cancer through Serial Analysis of Gene Expression: Prostate Stem Cell Antigen Is Overexpressed in Pancreatic Adenocarcinoma1... P Argani,C Rosty,RE Reiter,... 被引量: 0发表: 0年 Reduced Expression of PSCA, a Member of the LY-6 Family of Cell Surface Antigens...
We also compared the C-index values of our multi-cancer biomarker with those of other multi-cancer bio- markers reported in the literature. For model comparisons including clinical features (e. g. cancer stag- ing), we used the "other factors" option in SurvExpress. Results Identification of...
A variety of genetic abnormalities have occurred in the early stage of lung cancer or precancerous lesions. These abnormal changes often precede the appearance of clinical symptoms, and to a certain extent become molecular markers of early lung cancer. Therefore, relevant gene detection is useful ...
Roth for her excellent technical support. We acknowledge the work and contribution of T. Mack from Bristol Myers Squibb. L.R. was supported by the German Cancer Aid via the MSNZ program and IZKF Würzburg. H.E and M.H. were supported by the DFG via SFB/TR 221 project A3. A.-E.S...
Furthermore, epigenetic markers potentially serve as diagnostic, prognostic, and predictive biomarkers and might be used as novel targets for cancer precision medicine [17,18,19,20]. Here, we studied the expression and mutation of m6A-related genes in patients with cervical squamous cell carcinoma ...
In cancer studies, it is common that multiple microarray experiments are conducted to measure the same clinical outcome and expressions of the same set of genes. An important goal of such experiments is to identify a subset of genes that can potentially serve as predictive markers for cancer deve...
The CRISPR system is a revolutionary genome editing tool that has the potential to revolutionize the field of cancer research and therapy. The ability to precisely target and edit specific genetic mutations that drive the growth and spread of tumors has
Researchers at the Johns Hopkins Brady Urological Institute, Wake Forest University and the Karolinska Institute in Sweden have identified an array of gene markers for hereditary prostate cancer that, along with family history for the disease, appear to raise risk to more than nine times that of m...
Medicine have discovered new genetic markers to identify Lynch syndrome-associated colorectal cancer with high accuracy. Studies are underway to determine whether these genetic markers are in stool samples, and if so, how this could lead to a non-invasive screening option for patients with Lynch ...